C-PUVUclock.bio
rejuvenation biology, CRISPR screening, AI cell-age measurement
reprogramming
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
All companiesC-PUVU
C-PUVUC-PUVUrejuvenation biology, CRISPR screening, AI cell-age measurement
0-100 chain-logic scale · 15 dimensions · scored on public evidence
clock.bio rejuvenation biology, CRISPR screening, AI cell-age measurement
clock.health is developing a platform for human rejuvenation focused on decoding the rejuvenation genome, the genes and gene programs that enable cells to reverse aging. Its platform combines genome-wide CRISPR screening in human iPSCs, AI-driven biological age measurement from microscope images, and clinical validation through skin topical and nutraceutical interventions. The company aims to extend healthspan by reversing cellular aging rather than only slowing age-related decline.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
clock.bio — Early mechanism · Bottom quartile. Derived deterministically from 4 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic